Ovarian Cancer Canada - financial statements year ended Mar 2015/2014 (2 sources) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, May 11, 2016

Ovarian Cancer Canada - financial statements year ended Mar 2015/2014 (2 sources)





Website Sources:

Statement of operations year ended March 31, 2015: (*OCC)
Revenue
   2015                  2014
$4,281,688       $4,049,571
(Deficiency) excess of revenue over expenses for the year (*OCC)
   (257,956)            72,848
Investing activities
Proceeds from disposal of investments
$1,700,000           $1,100,000 (*OCC)
Research commitment
OCC has committed to pay $120,000 to a research organization in the year ending March 31,  2016.  These funds are to support OCC’s portion of the financial commitment for two grants for research in OCC’s core areas of focus over a two year period.  The OCC contribution will be matched by the research organization. (*OCC)
Additional information to comply with the disclosure requirements of the Charitable Fundraising
Act of Alberta
Remuneration paid to employees for activities involving fundraising, together with associated
employee benefits and statutory payroll costs, amounted to $591,043 (2014 - $603,949). (*OCC)

Compensation (*Canada Revenue Agency)
 Total compensation for all positions    $2,302,812
 Full-time employees:  28    Part-time employees: 12
Ten highest compensated full-time positions           $160,000 - $199,999: 1
$120,000 - $159,999: 1 $80,000 - $119,999: 7  $40,000 - $79,999: 1


 


0 comments :

Post a Comment

Your comments?